you are being redirected

You will be redirected to the website of our parent company, Schönherr Rechtsanwälte GmbH: www.schoenherr.eu

healthcare & life sciences

Schoenherr's experts provide straight-to-the-point legal advice in all legal matters in the healthcare & life sciences industry.

Schoenherr's healthcare group draws on a breadth of experience across the firm's practice areas. We combine specialist knowledge and experience with the insights and track-record of our market-leading transactional practice.

Our healthcare & life sciences team covers a wide range of subjects, including pharmaceuticals, biochemistry, chemicals, e-health, cosmetics, medical devices, toys, tobacco products, food and feed.

Partners Andreas Natterer and Paweł Halwa lead and coordinate the Schoenherr expert team. We act for and advise all stakeholders active in the healthcare, life sciences, biotech and pharma sectors. Areas of particular expertise are regulatory life sciences work and transactional advice regarding targets in the healthcare and life sciences industry.

legal areas

Working closely and in integrated teams with specialists in:

our services

Our full-service offering in the healthcare & life sciences sector covers:

  • medicinal products
  • drugs, (narcotic) substances
  • food and feed
  • tobacco and tobacco substitutes
  • medical devices
  • genetically modified organisms
  • chemicals
  • cosmetics
  • medical and care institutions advice as well as hospitals

Our advisory covers inter alia:

  • transactional advice including m&a, banking & finance, capital markets as well as real estate (development)
  • advising on the establishment, operation and transfer of group practices, primary health care units and outpatient clinics
  • assisting strategic and financial investors in respect of the acquisition of outpatient clinics as well as out- and inpatient hospitals
  • m&a and other transactional advice in connection with investments in and the takeover of targets operating in the health care and life sciences industries
  • advising on the qualification and classification of software as medical devices, on telemedicine, e-health and e-medication
  • advising on contracts for clinical trials, quality agreements, licensing, collaboration, research and other agreements relevant to the sector
  • supporting medical device, pharmaceutical and medical supply manufacturers in relation to regulatory clearance proceedings, product marketing and distribution, and business compliance
  • providing guidance on the exploitation, enforcement and defence of ip rights
  • representing clients in medical malpractice claims
  • investigating corporate crimes, compliance violations, confidential information leaks and breach of legal duties
  • crisis management such as advising in product recalls on national and international levels
  • representation before national/European authorities/courts
back contact us

 


 

news

newsletter

08 October 2024

bulgaria

E.Todorova

Regulating telemedicine and personalising healthcare: an overview of the latest revision to the Bulgarian Public Health Act

The amendments to the Bulgarian Public Health Act (PHA), introduced on 8 October 2024, are aimed at modernising the healthcare system, enhancing data management and improving patient care. They prioritise the transition to electronic health records (EHR), regulate telemedicine, and introduce a digital scheduling system for medical appointments. This article provides a high-level overview of the amendments.

more
roadmap

2024

CEE

CEE team

Youth and beauty (on the edge between cosmetics and medicine)

When prompted to list the top 10 human fears, an OpenAI language model started with the fear of death and ended with the fear of rejection. The AI's advice on how to overcome these fears was clearcut: accept the impermanence of life and find meaning.

more
publication

25 August 2023

austria

Global Legal Insights - Pricing & Reimbursement in Austria 2023

more

find all healthcare & life sciences news here


 

info corner

coronavirus info corner

The coronavirus presents us with completely new challenges. With the coronavirus info corner we aim to provide specifics about certain legal aspects surrounding Covid-19.

find out more

 

team

our team

Schoenherr's healthcare & life sciences team consists of experienced lawyers across all our CEE offices.

team